Shuji Ogino, MD, PhD, MS
Brigham and Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA
Dr. Shuji Ogino is currently Professor of Pathology at Harvard Medical School, Brigham and Women's Hospital and Dana-Farber Cancer Institute, and Professor in the Department of Epidemiology at Harvard T.H. Chan School of Public Health. He is also Chief of Program in MPE Molecular Pathological Epidemiology at Brigham and Women’s Hospital, and an associate member of Broad Institute of MIT and Harvard.
He is the only unique faculty member who holds appointments in both Pathology and Epidemiology at Harvard University and has played various major leadership roles in international and national societies. With unique combined expertise in both molecular pathology and epidemiology, Dr. Ogino has established a new discipline, molecular pathological epidemiology (abbreviated as MPE). Dr. Ogino has been conducting MPE research with a particular focus on colorectal carcinoma and his own research program has continuously been funded by NIH. Recently, Dr. Ogino has expanded the MPE paradigm to encompass immunology and microbiology.
Editorial Board
Terms of Appointment: July 2018 - July 2020